Amended final report on the safety assessment of glyceryl dilaurate, glyceryl diarachidate, glyceryl dibehenate, glyceryl dierucate, glyceryl dihydroxystearate, glyceryl diisopalmitate, glyceryl diisostearate, glyceryl dilinoleate, glyceryl dimyristate, glyceryl dioleate, glyceryl diricinoleate, glyceryl dipalmitate, glyceryl dipalmitoleate, glyceryl distearate, glyceryl palmitate lactate, ...

International Journal of Toxicology

Volumn 26, Issue SUPPL. 3, 2007, Pages 1-30

  Johnson Jr , Wilbur ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COSMETIC; DIACYLGLYCEROL DERIVATIVE; GLYCEROL DILINOLEATE; GLYCEROL DIPALMITATE; GLYCEROL DISTEARATE; GLYCERYL DIARACHIDATE; GLYCERYL DIBEHENATE; GLYCERYL DIERUCATE; GLYCERYL DIHYDROXYSTEARATE; GLYCERYL DIISOPALMITATE; GLYCERYL DIISOSTEARATE; GLYCERYL DILAURATE; GLYCERYL DIMYRISTATE; GLYCERYL DIOLEATE; GLYCERYL DIPALMITOLEATE; GLYCERYL DIRICINOLEATE; GLYCERYL PALMITATE LACTATE; GLYCERYL STEARATE CITRATE; GLYCERYL STEARATE LACTATE; GLYCERYL STEARATE SUCCINATE; UNCLASSIFIED DRUG; VEGETABLE OIL;

ANTIMICROBIAL ACTIVITY; BACTERIAL GROWTH; BACTERIAL STRAIN; CARCINOGENICITY; CELL GROWTH; CELL PROLIFERATION; CHEMICAL COMPOSITION; CHEMICAL STRUCTURE; DERMATITIS; ENZYME ACTIVITY; EYE IRRITATION; GENOTOXICITY; HUMAN; HYDROGENATION; MELTING POINT; MOLECULAR WEIGHT; NONHUMAN; PHOTOALLERGY; PHOTOTOXICITY; REVIEW; RISK ASSESSMENT; SIGNAL TRANSDUCTION; SKIN ABSORPTION; SKIN IRRITATION; SKIN PENETRATION; SKIN SENSITIZATION; SKIN TEST; SKIN TOXICITY; TOXICITY TESTING; TUMOR PROMOTION; ULTRAVIOLET RADIATION;

ANIMALS; CONSUMER PRODUCT SAFETY; COSMETICS; EMOLLIENTS; FATTY ACIDS; HUMANS; TOXICITY TESTS;

ANIMALIA; CAVIA; CRICETULUS GRISEUS; GLYCERINE; MAMMALIA; MUS; ORYCTOLAGUS CUNICULUS; RODENTIA;

EID: 37349061110     PISSN: 10915818     EISSN: 1092874X     Source Type: Journal    
DOI: 10.1080/10915810701663143     Document Type: Review

References (101)

1. 2
2. 2
3. 2
4. Agin, P. P., J. D. Dowdy, and M. E. Costlow. 1991. Diacylglycerol-induced melanogenesis in Skh-2 pigmented hairless mice. Photodermatol. Photoimmunol. Photomed. 8:51-56.
5. Allan, A. E., M. Archambault, E. Messana, and B. A. Gilchrest. 1995. Topically applied diacylglycerols increase pigmentation in guinea pig skin. J. Invest. Dermatol. 105:687-692.
6. Andersen, F. A., ed. 1998. Final report on the safety assessment of Glycolic Acid; Ammonium, Calcium, Potassium, and Sodium Glycolate; Lactic Acid; Ammonium, Calcium, Potassium, Sodium, TEA-Lactate; Methyl, Ethyl, Isopropyl, and Butyl Lactate and Lauryl, Myristyl, and Cetyl Lactate. Int. J. Toxicol. 17(S1):1-242.
7. Andersen, F. A., ed. 2001. Final report on the safety assessment of Trilaurin, Triarachidin, Tribehenin, Tricaprin, Tricaprylin, Trierucin, Triheptanoin, Triheptylundecanoin, Triisononanoin, Triisopalmitin, Triisostearin, Trilinolein, Trimyristin, Trioctanoin, Triolein, Tripalmitin, Tripalmitolein, Triricinolein, Tristearin, Triundecanoin, Glyceryl Triacetyl Hydroxystearate, Glyceryl Triacetyl Ricinoleate, and Glyceryl Stearate Diacetate. Int. J. Toxicol. 20:61-94.
8. Aungst, B. J., N. J. Rogers, and E. Shefter. 1986. Enhancement of naloxone penetration through human skin in vitro using fatty acids, fatty alcohols, surfactants, sulfoxides and amides. Int. J. Pharm. 33:225-234.
9. 2
10. 2
11. Blobe, G. C., L. M. Obeid, and Y. A. Hannun. 1994. Regulation of protein kinase C and role in cancer biology. Cancer Metastasis Rev. 13:411-431.
12. Blumberg, P. M., G. Acs, L. B. Areces, M. G. Kazanietz, N. E. Lewin, and Z. Szallasi. 1994. Protein kinase C in signal transduction and carcinogenesis. Prog. Clin. Biol. Res. 387:3-19.
13. Bögi, K., P. S. Lorenzo, S. Szállási, P. Ács, G. S. Wagner, and P. M. Blumberg. 1998. Differential selectivity of ligands for the C1a and C1b phorbol ester binding domains of proetin kinase Cdelta: Possible correlation with tumorpromoting activity. Cancer Res. 58:1423-1428.
14. 2
15. Caloca, M. J., M. L. Garcia-Bermejo, P. M. Blumberg, et al. 1999. Beta2-chimaerin is a novel target for diacylglycerol: binding properties and changes in subcellular localization mediated by ligand binding to its C1 domain. Proc. Natl. Acad. Sci. U. S. A. 96:11854-11859.
16. Conley, A. J., and J. J. Kabara. 1973. Antimicrobial action of esters of polyhydric alcohols. Antimicrob. Agents Chemother. 4:501-506.
17. 2
18. 2
19. 2
20. 2
21. 2
22. 2
23. 2
24. 2
25. 2
26. 2
27. De Groot, W. Th. 1972. Acyl migration solid phase isomerization of 1,2-diglycerides to 1,3-isomers. Lipids 7:626-628.
28. Elder, R. L., ed. 1982. Final report on the safety assessment of Glyceryl Stearate and Glyceryl Stearate/SE. J. Am. Coll. Toxicol. 1:169-192.
29. Elder, R. L., ed. 1983. Final report on the safety assessment of Isostearic Acid. J. Am. Coll. Toxicol. 2:61-74.
30. Elder, R. L., ed. 1987. Final report on the safety assessment of Oleic Acid, Lauric Acid, Palmitic Acid, Myristic Acid, and Stearic Acid. J. Am. Coll. Toxicol. 6:321-401.
31. Elder, R. L., ed. 1993. Final report on the safety assessment of Arachidonic Acid. J. Am. Coll. Toxicol. 12:481-559.
32. 2
33. European Economic Community (EEC). 2001. EEC Cosmetics Directive 76/768/EEC, as amended, Annexes I through VII. Brussels: EEC.
34. Federation of American Societies for Experimental Biology. 1975. Evaluation of the health aspects of glycerin and glycerides as food ingredients. NTIS Report No. PB 254 536.
35. Fitzhugh, O. G., P. J. Schouboe, and A. A. Nelson. 1960. Oral toxicities of lauric acid and certain lauric acid derivatives. Toxicol. Appl. Pharmacol. 2:59-67.
36. 2
37. FDA. 2002. Frequency of use of cosmetic ingredients. FDA database. Washington, DC: FDA
38. 2
39. 2
40. Giron, D., R. Link, and S. Bouissel. 1992. Analysis of mono-, di- and triglycerides in pharmaceutical excipients by capillary supercritical fluid chromatography. J. Pharm. Biomed. Anal. 10:821-830.
41. Go, M., K. Sekiguchi, H. Nomura, U. Kikkawa, and Y. Nishizuka. 1987. Further studies on the specificity of diacylglycerol for protein kinase C activation. Biochem. Biophys. Res. Commun. 144:598-605.
42. Hansen, L. A., N. A. Monteiro-Riviere, and R. C. Smart. 1990. Differential down-regulation of epidermal protein kinase C by 12-O-tetradecanoylphorbol-13-acetate and diacylglycerol: Association with epidermal hyperplasia and tumor promotion. Cancer Res. 50:5740-5745.
43. Hayakawa, R., K. Matsunaga, M. Suzuki, Y. Arima, and Y. Ohkido. 1987. Lipstick dermatitis due to C18 aliphatic compounds. Contact Dermatitis. 16:215-219.
44. 2
45. Informatics, Inc. 1973. GRAS (Generally Recognized as Safe) Food Ingredients - Glycerine and Glycerides. NTIS Report No. PB-221 227.
46. 2
47. 2
48. 2
49. 2
50. 2
51. 2
52. 2
53. Jensen, P. A., and D. Obrien. 1993. Industrial Hygiene. In: Aerosol measurement. Principles techniques and applications, ed. K. Willeke and P.A. Baron, 538-540. New York: John Wiley and Sons.
54. Johnsen, M. A. 2004. The influence of particle size. Spray Technology and Marketing. November:24-27.
55. Kabara, J. J., R. Vrable, and M. S. F. Lie Ken Jie. 1977. Antimicrobial lipids: Natural and synthetic fatty acids and monoglycerides. Lipids. 12:753-759.
56. Kasamatsu, T., R. Ogura, N. Ikeda, et al. 2005. Genotoxicity studies on dietary diacylglycerol (DAG) oil. Food Chem. Toxicol. 43:253-260.
57. König, B., P. A. DiNitto, and P. M. Blumberg. 1985. Stoichiometric binding of diacylglycerol to the phorbol ester receptor. J. Cell Biochem. 29:37-44.
58. Lee, J., V. E. Marquez, P. M. Blumberg, K. W. Krausz, and M. G. Kazanietz. 1993. Conformationally constrained analogues of diacylglycerol (DAG) - II. Differential interaction of delta-lactones and gamma-lactones with protein kinase C (PK-C). Bioorgan. Med. Chem. 1:119-123.
59. Lee, M. W., and D. L. Severson. 1994. Signal transduction in vascular smooth muscle: Diacylglycerol second messengers and PKC action. Am. J. Physiol. 267:C659-C678.
60. Lee, J., R. Sharma, S. Wang, G. W. A. Milne, N. E. Lewin, Z. Szallasi, P. M. Blumberg, C. George, and V. E. Marquez. 1996a. Conformationally constrained analogues of diacylglycerol. 12. Ultrapotent protein kinase C ligands based on a chiral 4,4-disubstituted heptono-1,4-lactone template. J. Med. Chem. 39:36-45.
61. Lee, J., S. Wang, G. W. A. Milne, R. Sharma, N. E. Lewin, P. M. Blumberg, and V. E. Marquez. 1996b. Conformationally constrained analogues of diacylglycerol. 11. Ultrapotent protein kinase C ligands based on a a chiral 5-disubstituted tetrahydro-2-furanone template. J. Med. Chem. 39:29-35.
62. Lëvy, L., V. Alvaro, C. Dubray, and D. Joubert. 1994. Ca(2+)-dependent protein kinase C isoforms in rat pituitary hyperplasia: Effect of in vivo treatment with quinagolide. Eur. J. Pharmacol. 16:327-334.
63. Lide, D. R., and H. P. R. Frederikse, eds. 1993. CRC handbook of chemistry and physics. A ready-reference book of chemical and physical data, 74th ed., 3-260-3-261, 3-502-3-504. Boca Raton, FL: CRC Press.
64. Mattson, F. H., and R. A. Volpenhein. 1964. The digestion and absorption of triglycerides. J. Biol. Chem. 239: 2772-2777.
65. 2
66. 2
67. 2
68. Mills, K. J., S. H. Reynolds, and R. C. Smart. 1993. Diacylglycerol is an effector of the clonal expansion of cells containing activated Ha-ras genes. Carcinogenesis. 14:2645-2648.
69. Ministry of Health, Labor and Welfare (MHLW). 2001a. Unofficial translation of MHW Ordinance No. 331, Attached Table 1 [Negative List]. Ministry of Health, Labor and Welfare, Pharmaceutical and Medical Safety Bureau, Inspection and Guidance Division, 2-2,1-chome, Kasumigaseki, Chiyoda-ku, Tokyo 100-8045, Japan.
70. MHLW. 2001b. Unofficial translation of MHW Ordinance No. 331, Attached Table 2 [Restricted List]. Ministry of Health, Labor and Welfare, Pharmaceutical and Medical Safety Bureau, Inspection and Guidance Division, 2-2,1-chome, Kasumigaseki, Chiyoda-ku, Tokyo 100-8045, Japan.
71. Mori, T., Y. Takai, B. Yu, J. Takahashi, Y. Nishizuka, and T. Fujikura. 1982. Specificity of the fatty acyl moieties of diacylglycerol for the activation of calcium-activated, phospholipid-dependent protein kinase. J. Biochem. 91:427-431.
72. National Academy of Sciences (NAS). 1960. The safety of mono- and diglycerides for use as intentional additives in food (NAS publication no. 251). Washington, DC: NAS.
73. Niederpruem, H., H. Schweikert, J. W. Thueroff, and K. S. Zaenker. 1995. Inhibition of steroid 5 alpha-reductase activity by aliphatic fatty acids. Candidates for chemoprevention of prostate cancer. Ann. N. Y. Acad. Sci. 768:227-230.
74. Nomura, H., A. Katsuhiko, K. Sekiguchi, U. Kikkawa, and Y. Nishizuka. 1986. Stereospecificity of diacylglycerol for stimulus-response coupling in platelets. Biochem. Biophys. Res. Commun. 140:1143-1151.
75. Pepe, R. C., J. A. Wenninger, G. N. McEwen, Jr., eds. 2002. International cosmetic ingredient dictionary and handbook, 9th ed., 675-677, 683, 686-687. Washington, DC: CTFA.
76. 2
77. 2
78. Punnonen, K., and S. H. Yuspa. 1992. Ultraviolet light irradiation increases cellular diacylglycerol and induces translocation of diacylglycerol kinase in murine keratinocytes. Invest. Dermatol. 99:221-226.
79. 2
80. Saffiotti, U., and P. Shubik. 1963. Studies on promoting action in skin carcinogenesis. Natl. Cancer Inst. Monogr. 10:489-507.
81. Sánchez-Piñera, P., V. Micol, S. Corbalán-Garcia, and J. C. Gómez-Fernández. 1999. A comparative study of the activation of protein kinase C α by different diacylglycerol isomers. Biochem. J. 337:387-395.
82. Scientific & Technical Information Network (STN) International. 1997. Properties of esters of glycerin and lauric acid. Registry database file. Columbus, OH: STN International.
83. Semba, M., and N. Inui. 1991. Inhibitory effects of radical scavengers on diacylglycerol-promoted transformation in Balb/3t3 cells. Toxicol. Lett. 56:299-303.
84. Serdarevich, B. 1967. Glyceride isomerizations in lipid chemistry. J. Am. Oil Chem. Soc. 44:381-393.
85. Setala, K., L. Stjernvall, M. Nyholm, L. Merenmies, and E. E. Miskanen. 1961. Mechanism of experimental tumorigenesis 7. Ultrastructural changes in mouse epidermis caused by glyceryl stearate-type tumor enhancers in acetone and in water. Acta Pathol. Microbiol. Scand. 51:305-320.
86. Sharkey, N. A., and P. M. Blumberg. 1985. Kinetic evidence that 1,2-diolein inhibits phorbol ester binding to protein kinase C via a competitive mechanism. Biochem. Biophys. Res. Commun. 133:1051-1056.
87. Sharkey, N. A., and P. M. Blumberg. 1986. Comparison of the activity of phorbol 12-myristate 13-acetate and the diglyceride glycerol 1-myristate 2-acetate. Carcinogenesis. 7:677-679.
88. Sharkey, N. A., K. L. Leach, and P. M. Blumberg. 1984. Competitive inhibition by diacylglycerol of specific phorbol ester binding. Proc. Natl. Acad. Sci. U. S. A. 81:607-610.
89. Sharkey, N. A., K. L. Leach, and P. M. Blumberg. 1986. Comparison of the activity of phorbol 12-myristate 13-acetate and the diglyceride glycerol 1-myristate 2-acetate. Carcinogenesis. 7:677-679.
90. Sharma, R., J. Lee, S. Wang, G. W. A. Milne, N. E. Lewin, P. M. Blumberg, and V. E. Marquez. 1996. Conformationally constrained analogues of diacylglycerol. 10. Ultrapotent protein kinase C ligands based on a racemic 5-disubstituted tetrahydro-2-furanone template. J. Med. Chem. 39:19-28.
91. 2
92. 2
93. Smart, R. C., M-T. Huang, and A. H. Conney. 1986. sn-1,2-Diacylglycerols mimic the effects of 12-O-tetradecanoylphobol-13-acetate in vivo by inducing biochemical changes associated with tumor promotion in mouse epidermis. Carcinogenesis. 7:1865-1870.
94. Smart, R. C., M-T. Huang, N. A. Monteiro-Riviere, C-Q. Wong, K. J. Mills, and A. H. Conney. 1988. Comparison of the effect of sn-1,2-didecanoylglycerol and 12-O-tetradecanoylphorbol-13-acetate on cutaneous morphology, inflammation and tumor promotion in CD-1 mice. Carcinogenesis. 9:2221-2226.
95. Smart, R. C., K. J. Mills, L. A. Hansen, and A. H. Conney. 1989. Synthetic lipid second messenger sn-1,2-didecanoylglycerol: A complete tumor promoter in mouse skin. Cancer Res. 49:4455-4458.
96. Soni, M. G., H. Kimura, and G. A. Burdock. 2001. Chronic study of diacylglycerol oil in rats. Food Chem. Toxicol. 39:317-329.
97. 2
98. Tanaka, M., S. Shimizu, and S. Miyakawa. 1993. Contact dermatitis from glyceryl di-isostearate. Contact Dermatitis. 29:41-42.
99. 2
100. Wang, H-Q., and R. C. Smart. 1999. Overexpression of protein kinase C-α in the epidermis of transgenic mice results in striking alterations in phorbol ester-induced inflammation and COX-2, MIP-2, and TNF-α expression but not tumor promotion. J. Cell Sci. 112:3497-3506.
101. Wender, P. A., K. F. Koehler, N. A. Sharkey, and M. L. Dell'Aquila. 1986. Analysis of the phorbol ester pharmacophore on protein kinase C as a guide to the rational design of new classes of analogs. Proc. Natl. Acad. Sci. U. S. A. 83:4214-4218.